Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple sclerosis; PF708, a peptide product candidate to treat high-risk fracture patients; and others. Pfenex’s preclinical products under development include PF529, a biosimilar candidate to neulasta; PF688, a biosimilar candidate to cimzia, PF444, PF690; and others. The company produces biosimilar product with protein production platform and bioanalytic approach. It partners with the US government for developing vaccines for anthrax and malaria. Pfenex is headquartered in San Diego, California, the US. Pfenex Inc Key Recent Developments Aug 03,2017: Pfenex Names Eef Schimmelpennink Chief Executive Officer May 08,2017: Pfenex Reports First Quarter 2017 Results and Provides Business Update Apr 03,2017: Sigurdur (Siggi) Olafsson And Jason Grenfell-Gardner Nominated To Serve On Board Of Directors Mar 31,2017: William R. Rohn Announces Plans To Retire As Chairman And Board Member Mar 15,2017: Pfenex Reports Fourth Quarter and Full Year 2016... Research Beam Model: Research Beam Product ID: 1943804 300 USD New
Pfenex Inc (PFNX) - Financial and Strategic SWOT Analysis Review
 
 

Pfenex Inc (PFNX) - Financial and Strategic SWOT Analysis Review

  • Category : Company Profiles
  • Published On : August   2017
  • Pages : 25
  • Publisher : GlobalData
 
 
 
Summary

Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple sclerosis; PF708, a peptide product candidate to treat high-risk fracture patients; and others. Pfenex’s preclinical products under development include PF529, a biosimilar candidate to neulasta; PF688, a biosimilar candidate to cimzia, PF444, PF690; and others. The company produces biosimilar product with protein production platform and bioanalytic approach. It partners with the US government for developing vaccines for anthrax and malaria. Pfenex is headquartered in San Diego, California, the US.

Pfenex Inc Key Recent Developments

Aug 03,2017: Pfenex Names Eef Schimmelpennink Chief Executive Officer
May 08,2017: Pfenex Reports First Quarter 2017 Results and Provides Business Update
Apr 03,2017: Sigurdur (Siggi) Olafsson And Jason Grenfell-Gardner Nominated To Serve On Board Of Directors
Mar 31,2017: William R. Rohn Announces Plans To Retire As Chairman And Board Member
Mar 15,2017: Pfenex Reports Fourth Quarter and Full Year 2016 Results and Provides Business Update

This comprehensive SWOT profile of Pfenex Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pfenex Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents

Section 1 - About the Company

Pfenex Inc - Key Information
Pfenex Inc - Overview
Pfenex Inc - Key Employees
Pfenex Inc - Key Employee Biographies
Pfenex Inc - Key Operational Heads
Pfenex Inc - Major Products and Services
Pfenex Inc - History
Pfenex Inc - Company Statement
Pfenex Inc - Locations And Subsidiaries
Pfenex Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Pfenex Inc - Business Description
Pfenex Inc - Corporate Strategy
Pfenex Inc - SWOT Analysis
SWOT Analysis - Overview
Pfenex Inc - Strengths
Pfenex Inc - Weaknesses
Pfenex Inc - Opportunities
Pfenex Inc - Threats
Pfenex Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Pfenex Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
List of Tables

Pfenex Inc, Key Information
Pfenex Inc, Key Ratios
Pfenex Inc, Share Data
Pfenex Inc, Major Products and Services
Pfenex Inc, History
Pfenex Inc, Key Employees
Pfenex Inc, Key Employee Biographies
Pfenex Inc, Key Operational Heads
Pfenex Inc, Other Locations
Pfenex Inc, Subsidiaries
Pfenex Inc, Key Manufacturing facilities
Pfenex Inc, Key Competitors
Pfenex Inc, SWOT Analysis
Pfenex Inc, Ratios based on current share price
Pfenex Inc, Annual Ratios
Pfenex Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios List of Figures

Pfenex Inc, Performance Chart
Pfenex Inc, Ratio Charts
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter